Lyka Labs Ltd
Lyka Labs | 500259
LYKALABS - Share Price Chart
Stock Performance
Ratios
About Company
- Initially manufacturing formulations, Lyka Labs Limited brought bulk drugs into its operational fold by amalgamating Lyphin Chemicals Pvt Ltd with itself in Apr
- It also added a range of ayurvedic and animal health care products over the years
- In 1990, it diversified into marketing medical and diagnostic equipment and instruments of Bekton Dickinson, US; Airsep Corporation, US; Coloplast, Denmark; and Terumo Corporation, Japan
- Lyka Exports is the subsidiary of the company
- The Company is engaged in the development, manufacture and marketing of quality finished dosages
- The company offers a broad range of antibiotics used as life-savers and to treat minor infections
- It has a fairly widespread product base with tropical steroids for skin disorders, anti-cancer products, cardio-vascular drugs and anti-inflammatory products
- Lyka introduced, in India, cough lozenges containing dextromethorphan hydrobromide (DMR), favoured internationally as an effective and safe cough suppressant
- Lyka has two formulations division and a bulk drugs division
- It also set up additional manufacturing facilities for ointments
Research Calls
Technical Indicators
Pivot Points
Volume Analysis
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
No Data Available
No Block Deals data available for this company.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Top Gainers
Top Losers
Group Stocks
Frequently Asked Questions
What is Share Price of Lyka Labs Ltd?
The current share price of Lyka Labs Ltd (Lyka Labs) is ₹73.62. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Lyka Labs Ltd?
The Price-to-Earnings (P/E) ratio of Lyka Labs Ltd is 73.62. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Lyka Labs Ltd?
Lyka Labs Ltd has a 52-week high of ₹102.99 and a 52-week low of ₹44.10. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Lyka Labs Ltd?
Lyka Labs Ltd offers a dividend yield of 0.00%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Lyka Labs Ltd?
The Earnings Per Share (EPS) of Lyka Labs Ltd is ₹-2.46. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Lyka Labs Ltd?
Lyka Labs Ltd has a Return on Equity (ROE) of 0.00%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
